Editorial: Diagnostic, prognostic and predictive factors of response in the era of precision oncology in breast cancer

by Diletta Favero, Diletta Favero, Daniele Generali, Daniele Generali, Francesco Schettini, Francesco Schettini, Francesco Schettini
Published 2023-11-01

Dissecting the biological heterogeneity of HER2-positive breast cancer

by Francesco Schettini, Aleix Prat
Published 2021-10-01

Health monitoring of electromechanical flight actuators via position-tracking predictive models

by Gianpietro Di Rito, Francesco Schettini
Published 2018-04-01

Therapeutic resistance and optimal drug sequencing in HER2-positive metastatic breast cancer: unmet needs and future perspectives

by Francesco Schettini, Fabiola Giudici, Daniele Generali
Published 2024-01-01

Self-monitoring electro-mechanical actuator for medium altitude long endurance unmanned aerial vehicle flight controls

by Gianpietro Di Rito, Roberto Galatolo, Francesco Schettini
Published 2016-05-01

Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment

by Caterina Gianni, Michela Palleschi, Giuseppe Schepisi, Chiara Casadei, Sara Bleve, Filippo Merloni, Marianna Sirico, Samanta Sarti, Lorenzo Cecconetto, Giandomenico Di Menna, Francesco Schettini, Francesco Schettini, Francesco Schettini, Ugo De Giorgi
Published 2022-08-01

BRAF Signaling Inhibition in Glioblastoma: Which Clinical Perspectives?

by Victoria Bouchè, Giovanni Aldegheri, Carmine Antonio Donofrio, Antonio Fioravanti, Samuel Roberts-Thomson, Stephen B. Fox, Francesco Schettini, Francesco Schettini, Daniele Generali, Daniele Generali
Published 2021-11-01

A perspective on the development and lack of interchangeability of the breast cancer intrinsic subtypes

by Francesco Schettini, Fara Brasó-Maristany, Nicole M. Kuderer, Aleix Prat
Published 2022-07-01

Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational st...

by Pietro De Placido, Erica Pietroluongo, Carmine De Angelis, Carmine De Angelis, Margherita Tafuro, Chiara Barraco, Rosa Giannatiempo, Roberto Buonaiuto, Francesco Schettini, Francesco Schettini, Francesco Schettini, Anna Iervolino, Emilia Anna Vozzella, Mario Giuliano, Mario Giuliano, Roberto Bianco, Grazia Arpino
Published 2022-08-01

Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report

by Francesco Schettini, Francesco Schettini, Francesco Schettini, Elia Seguí, Elia Seguí, Benedetta Conte, Esther Sanfeliu, Esther Sanfeliu, Esther Sanfeliu, Blanca Gonzalez-Farre, Blanca Gonzalez-Farre, Pedro Jares, Pedro Jares, Sergi Vidal-Sicart, Sergi Ganau, Isaac Cebrecos, Isaac Cebrecos, Fara Brasó-Maristany, Montserrat Muñoz, Montserrat Muñoz, Aleix Prat, Aleix Prat, Aleix Prat, Aleix Prat, Maria Vidal, Maria Vidal, Maria Vidal, Maria Vidal
Published 2022-11-01

Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents

by Giovanna Garufi, Luisa Carbognin, Francesco Schettini, Elia Seguí, Alba Di Leone, Antonio Franco, Ida Paris, Giovanni Scambia, Giampaolo Tortora, Alessandra Fabi
Published 2022-08-01

Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests

by Mariarosaria Saponaro, Luigi Annunziata, Antonella Turla, Ilaria Viganò, Michele De Laurentiis, Mario Giuliano, Lucia Del Mastro, Filippo Montemurro, Fabio Puglisi, Carmine De Angelis, Giuseppe Buono, Francesco Schettini, Grazia Arpino
Published 2022-11-01

Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial

by Francesco Schettini, Francesco Schettini, Silvia Paola Corona, Silvia Paola Corona, Fabiola Giudici, Fabiola Giudici, Carla Strina, Marianna Sirico, Ottavia Bernocchi, Ottavia Bernocchi, Manuela Milani, Nicoletta Ziglioli, Sergio Aguggini, Carlo Azzini, Giuseppina Barbieri, Valeria Cervoni, Maria Rosa Cappelletti, Alfredo Molteni, Maria Chiara Lazzari, Giuseppina Ferrero, Marco Ungari, Elena Marasco, Alice Bruson, Luciano Xumerle, Elisa Zago, Davide Cerra, Marco Loddo, Gareth H. Williams, Ida Paris, Ida Paris, Giovanni Scambia, Giovanni Scambia, Daniele Generali, Daniele Generali
Published 2021-06-01

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors

by Francesco Schettini, Irene De Santo, Carmen G. Rea, Pietro De Placido, Luigi Formisano, Mario Giuliano, Mario Giuliano, Grazia Arpino, Michelino De Laurentiis, Fabio Puglisi, Fabio Puglisi, Sabino De Placido, Lucia Del Mastro, Lucia Del Mastro
Published 2018-12-01

Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study

by Massimo Di Maio, Claudia Bighin, Francesco Schettini, Tommaso Ruelle, Laura Marandino, Alessandra Fabi, Carmine De Angelis, Mario Giuliano, Pietro De Placido, Michelino De Laurentiis, Ferdinando Riccardi, Caterina Picotto, Fabio Puglisi, Lucia Del Mastro, Grazia Arpino
Published 2023-12-01

Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study

by Francesco Schettini, Silvana Saracchini, Anna Bassini, Wally Marus, Serena Corsetti, Ilaria Specogna, Manuela Bertola, Elvia Micheli, Ralph M. Wirtz, Mark Laible, Uğur Şahin, Carla Strina, Manuela Milani, Sergio Aguggini, Richard Tancredi, Elena Fiorio, Sandro Sulfaro, Daniele Generali
Published 2024-08-01

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

by Olga Martínez-Sáez, Nuria Chic, Tomás Pascual, Barbara Adamo, Maria Vidal, Blanca González-Farré, Esther Sanfeliu, Francesco Schettini, Benedetta Conte, Fara Brasó-Maristany, Adela Rodríguez, Débora Martínez, Patricia Galván, Ana Belén Rodríguez, Antonio Martinez, Montserrat Muñoz, Aleix Prat
Published 2020-05-01

Computational reactive–diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving Olaparib

by Francesco Schettini, Maria Valeria De Bonis, Carla Strina, Manuela Milani, Nicoletta Ziglioli, Sergio Aguggini, Ignazio Ciliberto, Carlo Azzini, Giuseppina Barbieri, Valeria Cervoni, Maria Rosa Cappelletti, Giuseppina Ferrero, Marco Ungari, Mariavittoria Locci, Ida Paris, Giovanni Scambia, Gianpaolo Ruocco, Daniele Generali
Published 2023-07-01

Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified accordin...

by Luisa Carbognin, Michele Simbolo, Anna Caliò, Caterina Vicentini, Pietro Delfino, Isabella Sperduti, Matteo Fassan, Francesco Schettini, Maria Vittoria Dieci, Gaia Griguolo, Sara Pilotto, Elena Fiorio, Grazia Arpino, Valentina Guarneri, Sabino De Placido, Pierfranco Conte, Erminia Manfrin, Matteo Brunelli, Giovanni Scambia, Aldo Scarpa, Giampaolo Tortora, Emilio Bria
Published 2020-04-01

Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis

by Francesco Schettini, Mario Giuliano, Fabiola Giudici, Benedetta Conte, Pietro De Placido, Sergio Venturini, Carla Rognoni, Angelo Di Leo, Mariavittoria Locci, Guy Jerusalem, Lucia Del Mastro, Fabio Puglisi, PierFranco Conte, Michelino De Laurentiis, Lajos Pusztai, Mothaffar F. Rimawi, Rachel Schiff, Grazia Arpino, Sabino De Placido, Aleix Prat, Daniele Generali
Published 2021-03-01